Abstract:This study was designed to identify serum and amniotic fluid (AF) metabolic profile changes in response to gestational diabetes mellitus (GDM) and explore the association with maternal–fetal outcomes. We established the GDM rat models by combining a high-fat diet (HFD) with an injection of low-dose streptozotocin (STZ), detected the fasting plasma glucose (FPG) of pregnant rats in the second and third trimester, and collected AF and fetal rats by cesarean section on gestational day 19 (GD19), as well as measuring the weight and crown–rump length (CRL) of fetal rats. We applied liquid chromatography–tandem mass spectrometry (LC-MS/MS) for the untargeted metabolomics analyses of serum and AF samples and then explored their correlation with maternal–fetal outcomes via the co-occurrence network. The results showed that 91 and 68 metabolites were upregulated and 125 and 78 metabolites were downregulated in serum and AF samples exposed to GDM, respectively. In maternal serum, the obvious alterations emerged in lipids and lipid-like molecules, while there were great changes in carbohydrate and carbohydrate conjugates, followed by amino acids, peptides, and analogs in amniotic fluid. The altered pathways both in serum and AF samples were amino acid, lipid, nucleotide, and vitamin metabolism pathways. In response to GDM, changes in the steroid hormone metabolic pathway occurred in serum, and an altered carbohydrate metabolism pathway was found in AF samples. Among differential metabolites in two kinds of samples, there were 34 common biochemicals shared by serum and AF samples, and a mutual significant association existed. These shared differential metabolites were implicated in several metabolism pathways, including choline, tryptophan, histidine, and nicotinate and nicotinamide metabolism, and among them, N1-methyl-4-pyridone-3-carboxamide, 5’-methylthioadenosine, and kynurenic acid were significantly associated with both maternal FPG and fetal growth. In conclusion, serum and AF metabolic profiles were remarkably altered in response to GDM. N1-Methyl-4-pyridone-3-carboxamide, 5’-methylthioadenosine, and kynurenic acid have the potential to be taken as biomarkers for maternal–fetal health status of GDM. The common and inter-related differential metabolites both in the serum and AF implied the feasibility of predicting fetal health outcomes via detecting the metabolites in maternal serum exposed to GDM.

[Metabolomic Network Analysis of Umbilical Cord Blood of Gestational Diabetes Mellitus Patients Via Liquid Chromatography-Mass Spectrometry].

Genome-wide DNA Methylation Profiling in Infants Born to Gestational Diabetes Mellitus

Non-Targeted Metabolomics Analysis of Mother and Infant in Gestational Diabetes Mellitus and Neonatal Clinical Characterization

Metabolic Profiling of Plasma in Gestational Diabetes Mellitus Using Liquid Chromatography and Q-TOF Mass Spectrometry.

Placental metabolic profiling in gestational diabetes mellitus: An important role of fatty acids

Differentiation of Gestational Diabetes Mellitus by Nuclear Magnetic Resonance-Based Metabolic Plasma Analysis

Landscapes of maternal and neonatal gut microbiome and plasma metabolome signatures and their interaction in gestational diabetes mellitus

Unique Biomarker Characteristics in Gestational Diabetes Mellitus Identified by LC-MS-Based Metabolic Profiling

Increased Methylation at Differentially Methylated Region of GNASin Infants Born to Gestational Diabetes

Untargeted metabolomics study of mature human milk from women with and without gestational diabetes mellitus

Comparative proteomic analysis of maternal peripheral plasma and umbilical venous plasma from normal and gestational diabetes mellitus pregnancies.

Clinical significance of ultrasonic umbilical artery flow analysis in pregnancy with gestational diabetes mellitus

Serum and Amniotic Fluid Metabolic Profile Changes in Response to Gestational Diabetes Mellitus and the Association with Maternal–Fetal Outcomes

Plasma metabolites, especially lipid metabolites, are altered in pregnant women with gestational diabetes mellitus

Metallome-Wide Association Study of Maternal-Fetus Interface Metabolism Dysfunction in Gestational Diabetes Mellitus

Association of maternal blood metabolomics and gestational diabetes mellitus risk: a systematic review and meta-analysis

Gestational diabetes mellitus decreased umbilical cord blood polyunsaturated fatty acids: a meta-analysis of observational studies

Longitudinal metabolomics integrated with machine learning identifies novel biomarkers of gestational diabetes mellitus

Multiple Elements Related to Metabolic Markers in the Context of Gestational Diabetes Mellitus in Meconium.

The mediating role of maternal metabolites between lipids and adverse pregnancy outcomes of gestational diabetes mellitus

Altered gut bacterial and metabolic signatures and their interaction in gestational diabetes mellitus